1. Aggleton, J. P., and Passingham, R. E., 1981, Syndrome produced by lesions of the amygdala in monkeys (Macaca mulatta), J. Comp. Physiol. Psychol. 6: 961–977.
2. Aigner, T. G., and Mishkin, M., 1986, The effects of physostigmine and scopolamine on recognition memory in monkeys, Behav. Neural Biol. 45: 81–87.
3. Aigner, T., Mitchell, S., Aggleton, J., DeLong, M., Atruble, R., Price, D., and Mishkin, M., 1984, Effects of scopolamine and physostigmine on recognition memory in monkeys after ibotenic acid injections into the area of the nucleus basalis of Meynert, in: Alzheimer’s Disease: Advances in Basic Research and Therapies ( R. J. Wurtman, s. H. Corkin, and J. H. Growdon, eds.), Center for Brain Sciences and Metabolism, Cambridge, MA, p. 429.
4. Aikawa, H., Suzuki, K., Iwasaki, Y., and Iizuka, R., 1985, Atypical Alzheimer’s disease with spastic paresis and ataxia, Ann. Neurol. 17: 297–300.
5. Alexander, M. P., and Freedman, M., 1984, Amnesia after anterior communicating artery aneurysm rupture, Neurology 34: 752–757.